For decades, sleep apnea research focused primarily on men, leaving women's cardiovascular risks poorly understood. That gap has consequences: women often receive delayed diagnoses and may face different treatment thresholds than their male counterparts. A 2024 study in the European Heart Journal tracked cardiovascular outcomes in women with obstructive sleep apnea. The results show that severe sleep apnea more than doubles a woman's risk of heart attack, stroke, and related cardiovascular events (Bublitz et al., 2024). These findings matter because women represent nearly half of all sleep apnea cases but remain underdiagnosed. The research provides the sex-specific data that physicians need to make informed treatment decisions for their female patients.

Severe OSA Doubles Heart Risk

Women with severe obstructive sleep apnea faced 2.3 times higher odds of experiencing major cardiovascular events compared to women without sleep apnea. The study defined major adverse cardiovascular events as heart attack, stroke, coronary revascularization procedures, or cardiovascular death. This risk increase stood out when compared to other cardiovascular risk factors. For context, having diabetes typically increases cardiovascular risk by 2 to 4 times, while high blood pressure raises risk by 1.5 to 2 times. The sleep apnea risk falls squarely within this range of established cardiovascular threats. The researchers measured sleep apnea severity using the apnea-hypopnea index (AHI), which counts breathing interruptions per hour of sleep. Severe OSA requires an AHI of 30 or higher, meaning at least 30 breathing stops or significant reductions per hour. Women in this severe category showed the clearest cardiovascular risk increase.

Six Years of Sleep and Heart Tracking

The study followed 1,464 middle-aged women for a median of 6.3 years, using overnight sleep laboratory testing and comprehensive medical records. Participants underwent polysomnography, the standard sleep study that monitors brain waves, breathing patterns, oxygen levels, and heart rhythm throughout the night. Researchers recruited women from sleep clinics across multiple medical centers, creating a diverse cohort with ages ranging from 20 to 90 years, though most participants fell between 40 and 6

The median age was 63 years at study entry. This age range captures the period when cardiovascular risk typically accelerates in women, particularly after menopause. The follow-up period allowed researchers to track real-world outcomes rather than relying on short-term measures or surrogate endpoints. They documented 135 major cardiovascular events during the observation period, providing sufficient statistical power to detect meaningful associations between sleep apnea severity and heart outcomes. Participants came from established sleep disorder centers, which meant they had clinical-grade sleep testing rather than home-based screening tools. This approach ensured accurate OSA diagnosis and severity classification, though it may limit generalizability to women who have not yet sought sleep medicine evaluation.

Risk Persists Despite Other Factors

The cardiovascular risk from severe sleep apnea remained higher even after researchers accounted for traditional heart disease risk factors. The statistical models adjusted for age, body mass index, hypertension, diabetes, and other cardiovascular conditions that commonly occur alongside sleep apnea. This adjustment process, called multivariate analysis, helps isolate the independent contribution of sleep apnea to cardiovascular risk. Many sleep apnea patients also have obesity, high blood pressure, or diabetes, making it challenging to determine which condition drives the increased heart risk. The analysis suggests sleep apnea contributes cardiovascular harm beyond these other factors. The persistence of risk after adjustment strengthens the case that sleep apnea directly affects cardiovascular health rather than simply serving as a marker for other conditions. Proposed mechanisms include repeated oxygen drops that stress the cardiovascular system, surges in blood pressure during breathing interruptions, and chronic inflammation triggered by fragmented sleep. Women showed this independent risk pattern despite typically having different OSA presentations than men. Female patients often report fatigue, mood changes, and insomnia rather than the loud snoring and witnessed breathing pauses that characterize male presentations.

Breathing Interruptions Above 30 Per Hour

Women with apnea-hypopnea index values exceeding 30 events per hour faced the strongest association with heart attacks and strokes. This threshold defines severe OSA and represents one breathing interruption every two minutes during sleep. The dose-response relationship appeared most pronounced at this severe level, though the study found higher risk beginning with moderate OSA (AHI 15-30). Women with mild OSA (AHI 5-15) showed some increased cardiovascular events, but the association did not reach statistical significance in this cohort. The AHI threshold of 30 may prove particularly relevant for treatment decisions in women. Current clinical guidelines typically recommend continuous positive airway pressure (CPAP) therapy for severe OSA regardless of symptoms, while moderate OSA treatment depends more heavily on symptom severity and patient preferences. The clear cardiovascular risk increase at AHI levels above 30 supports more aggressive treatment approaches for women reaching this threshold. The finding also suggests that women might benefit from cardiovascular risk assessment as part of their sleep apnea evaluation, particularly those with severe disease.

Oxygen Drops Predict Heart Events

Nocturnal hypoxemia duration independently predicted cardiovascular outcomes, adding another dimension to sleep apnea's cardiovascular impact. Hypoxemia refers to periods when blood oxygen levels drop below normal ranges during sleep, typically measured as time spent below 90% oxygen saturation. This finding suggests that the cardiovascular harm from sleep apnea relates not just to breathing interruption frequency but also to the severity and duration of oxygen drops. Some patients experience brief, shallow oxygen dips, while others have prolonged periods of significant desaturation. The oxygen measurement provides additional prognostic information beyond the standard AHI. Two patients might have similar apnea-hypopnea index scores but very different patterns of oxygen desaturation. The patient with longer, deeper oxygen drops appears to face higher cardiovascular risk based on these results. This relationship points toward more sophisticated risk stratification approaches that consider multiple sleep study parameters rather than relying solely on breathing event counts. Advanced sleep laboratories already measure oxygen patterns routinely, making this additional risk factor readily available for clinical decision-making.

Women Need Different Screening Approaches

The findings highlight the need for sex-specific OSA screening that looks beyond typical male-predominant symptoms like loud snoring and witnessed apneas. Women often present with fatigue, morning headaches, mood disturbances, and insomnia rather than the classic presentation patterns derived from male-dominated research. This symptom difference contributes to diagnostic delays in women, who may receive treatment for depression, anxiety, or other conditions before anyone considers sleep apnea. The cardiovascular risk documented in this study adds urgency to improving female OSA recognition and diagnosis. Physicians should consider sleep apnea evaluation for women presenting with unexplained cardiovascular events, especially when traditional risk factors do not fully explain the clinical picture. The combination of sleep complaints and cardiovascular symptoms might warrant sleep study referral even without obvious sleep apnea warning signs. The research also suggests that cardiovascular risk assessment should become a standard component of sleep apnea evaluation in women. Patients with severe OSA might benefit from more intensive cardiovascular monitoring and preventive interventions beyond sleep apnea treatment alone.

Earlier CPAP Treatment Consideration

The results support earlier CPAP consideration in women with moderate-to-severe OSA, particularly given the clear cardiovascular risk increase. Current treatment algorithms often emphasize symptom severity alongside AHI values, but the cardiovascular findings suggest that objective disease severity might warrant more weight in treatment decisions. CPAP therapy works by providing continuous air pressure that keeps the upper airway open during sleep, preventing the breathing interruptions and oxygen drops that characterize sleep apnea. Multiple studies have shown that effective CPAP use can reduce blood pressure, improve heart function markers, and potentially decrease cardiovascular event rates. The timing of this research proves particularly relevant given recent mixed results from large CPAP trials that included both men and women. Those studies showed modest cardiovascular benefits, leading some to question the strength of the OSA-cardiovascular connection. The sex-specific analysis suggests that treatment effects might differ between men and women. Women facing moderate-to-severe OSA might benefit from discussions about cardiovascular risk reduction as a treatment goal alongside traditional outcomes like daytime sleepiness improvement. This framing could influence treatment decisions and adherence, especially for patients who do not experience dramatic symptom relief with CPAP therapy.

Conclusion

This research fills a critical gap in sleep medicine by providing robust, sex-specific data on cardiovascular outcomes in women with obstructive sleep apnea. The 2.3-fold increase in major cardiovascular events among women with severe OSA establishes sleep apnea as a significant cardiovascular risk factor that demands clinical attention. The findings have immediate practical implications for physicians treating middle-aged women. Sleep apnea screening should expand beyond traditional symptom patterns, and cardiovascular risk assessment should inform treatment decisions alongside symptom severity. Women with severe OSA, particularly those with significant nocturnal oxygen drops, may warrant earlier and more intensive treatment approaches. For women concerned about heart health, these results underscore the importance of addressing sleep quality and breathing patterns as part of comprehensive cardiovascular prevention. Sleep apnea represents a modifiable risk factor that, unlike age or genetics, responds to treatment interventions.

References

Bublitz, M. M., Danoff-Burg, S., Revilla, J. C., et al. (2024). Obstructive sleep apnea and incident cardiovascular events in women

Severe Sleep Apnea Raises Heart Event Risk in Women